Autobio Ebitda from 2010 to 2025

603658 Stock   40.09  0.11  0.27%   
Autobio Diagnostics' EBITDA is increasing over the years with slightly volatile fluctuation. EBITDA is expected to dwindle to about 1.3 B. From 2010 to 2025 Autobio Diagnostics EBITDA quarterly data regression line had arithmetic mean of  1,029,269,869 and r-squared of  0.74. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
B
Current Value
1.3 B
Quarterly Volatility
487.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Autobio Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Autobio Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 29.6 M, Selling General Administrative of 373.1 M or Total Revenue of 5.4 B, as well as many indicators such as . Autobio financial statements analysis is a perfect complement when working with Autobio Diagnostics Valuation or Volatility modules.
  
This module can also supplement various Autobio Diagnostics Technical models . Check out the analysis of Autobio Diagnostics Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Autobio Stock

Autobio Diagnostics financial ratios help investors to determine whether Autobio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Autobio with respect to the benefits of owning Autobio Diagnostics security.